baber/WOPTO huggingface dataset:
Patent DK-0393861-T3 (DK)
Inventor: GODFREY CHRISTOPHER RICHARD AY
IPC: A01N43/54
Filed: 1990-03-27
Granted: 1994-05-24
Abstract: Fungicidal compounds having the formula (I): <CHEM> in which any two of K, L and M are nitrogen and the other is CE; X and Y are independently hydrogen, halogen, C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkenyl, C2-4 alkynyl, C2-4 alkenyloxy, C2-4 alkynyloxy, phenyl, benzyloxy, cyano, isocyano, isothiocyanato, nitro, NR<1>R<2>, NR<1>OR<2>, N3, NHCOR<1>, NR<1>CO2R<2>, NHCONR<1>R<2>, N=CHNR<1>R<2>, NHSO2R<1>, OR<1>, OCOR<1>, OSO2R<1>, SR<1>, SOR<1>, SO2R<1>, SO2OR<1>, SO2NR<1>R<2>, COR<1>, CR<1>=NOR<2>, CHR<1>CO2R<2>, CO2R<1>, CONR<1>R<2>, CSNR<1>R<2>, CH3O2C.C:CH.OCH3, 1-(imidazol-1-yl)vinyl, a 5-membered heterocyclic ring containing one, two or three nitrogen heteroatoms, or a 5- or 6-membered heterocyclic ring containing one or two oxygen or sulphur heteroatoms, optionally a nitrogen heteroatom and optionally one or two oxo or thioxo substituents; or X and Y, when ortho to one another, join to form a 5- or 6-membered aliphatic or aromatic ring optionally containing one or two oxygen, sulphur or nitrogen atoms or one, two or three nitrogen or sulphur atoms; A, B, E, G and U are independently hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, cyano, nitro or trifluoromethyl; and R<1> and R<2> are independently hydrogen, C1-4 alkyl, C2-4 alkenyl or phenyl; the aliphatic moieties of any of the foregoing being optionally substituted with one or more of halogen, cyano, OR<1>, SR<1>, NR<1>R<2>, SiR<1>3 or OCOR<1> and the phenyl moieties of any of the foregoing being optionally substituted with one or more of halogen, C1-4 alkyl, C1-4 alkoxy, nitro or cyano; and their pyridine N-oxides and N-alkyl pyridinium salts.
Patent DK-0472651-T3 (DK)
Inventor: GARY D BARSOMIAN
IPC: C12N9/80
Filed: 1990-05-09
Granted: 2001-09-17
Abstract: An enzyme sample having Peptide-N<4>-(N-acetyl- beta -N-glucosaminyl) asparagine Aminidase F (PNGase F) activity completely free from Endo- beta -N-acetylglucosaminidase F (Endo F) activity.
Patent DK-0495814-T3 (DK)
Inventor: WOLF BERND MICHAEL
IPC: A62D3/40
Filed: 1990-10-06
Granted: 1994-08-15
Abstract: In a process for the disposal of toxic and/or infectious waste, especially highly halogenated solids, plastic containers, hospital waste and the like, to recover useful substances and render inert non-recyclable and unoutgassable residues, outgassing by the pyrolytic process is used, with air excluded and a reduced oxygen content, followed by the direct incineration of the distillation gases obtained from pyrolysis or their cracking to form a pyrolysis separation gas. The waste to be disposed of is inserted in an autoclave (2), partially outgassed there for a period of 20 minutes to 6 hours at about 250 to 320 C in an initial outgassing stage, then cooled and made into a granulate or pellets measuring from 1 to 50 mm, which are subsequently treated by the pyrolysis outgassing method in a second outgassing stage at a temperature of 550 to 600 C. This generates distillation gas which is separated from the residues, like carbon, ash, heavy metal particles and other components. The liquid partial outgassing intermediate products, like oil and/or coal tars, produced in the autoclave (2) are taken to the second outgassing stage, while the distillation gas separated off in the first outgassing stage in the autoclave (2) is taken off and added to the stream of distillation gas from the second outgassing stage.
Patent DK-0536177-T3 (DK)
Inventor: DIMAIO JOHN
IPC: A61K38/55
Filed: 1991-06-14
Granted: 1998-07-27
Abstract: A thrombin inhibitor comprising a first bulky hydrophobic portion interacting with the catalytic site of thrombin responsible for proteolysis and a second portion at least maintaining the hydrophobic and acidic character of amino acids 55 to 60 of native hirudin at the C-terminal non-catalytic region of N-acetyl-hirudin45-65. Between the first and second portions is a divalent linker moiety having a chain length of at least 10 carbon atomes. Preferably, the bulky hydrophobic portion comprises at least one amino acid of D-configuration. The compounds are useful in the treatment of thrombotic disorders.
Patent DK-0522756-T3 (DK)
Inventor: MATZ GARY F
IPC: A61K8/00
Filed: 1992-06-26
Granted: 1996-06-24
Abstract: Ampholyte terpolymer conditioning additives for skin and nail care products are disclosed which improve softening or lubricating (lubricity), moisture retention and attraction (moisturizing), feel, and reduction of irritation. The ampholyte terpolymers may have a weight average molecular weight of from about 10 thousand to 10 million, and comprise (a) from at least 1 to as much as 95 weight percent of a nonionic monomer, (b) from at least 5 to as much as 80 weight percent of a cationic monomer, and (c) from at least 1 to as much as 75 weight percent of an anionic monomer. The ampholyte terpolymers are added to skin and nail care product formulations in amounts ranging from 0.1-10% by weight.
Patent DK-0537895-T3 (DK)
Inventor: PARKER FRED T
IPC: A61M25/02
Filed: 1992-09-10
Granted: 1996-12-09
Abstract: A soft tip angioplasty balloon catheter having mating internal and external tapers for bonding the soft tip to the main portion of the catheter. The main portion includes a dual lumen tube and a single lumen tube extending from the distal end thereof. A circularly shaped passageway for insertion over a wire guide extends longitudinally through the entire main portion and soft tip of the catheter. A second, crescent or quarter-moon shaped passageway extends through the dual lumen tube and communicates with the interior of an uninflated angioplasty balloon for the inflation thereof. The balloon is positioned and stored around the smaller diameter single lumen tube. The angioplasty balloon is attached about the distal end of the dual lumen tube and the proximal end of the soft tubular tip. The distal end of the balloon is positioned in an annular recess about the proximal end of the soft tip with an outside diameter that approximates the maximum outside diameter of the catheter about the main portion. Tungsten ring markers are positioned around the single lumen tube to indicate the position of the angioplasty balloon when in a coronary vessel. The distal end of the soft tip is also externally tapered to minimize trauma to a coronary vessel wall. The tubular tip comprises a material having a durometer softer than that of the main portion for further minimizing trauma to a coronary vessel wall.
Patent DK-0571538-T3 (DK)
Inventor: BRILES DAVID E
IPC: A61P31/04
Filed: 1992-02-12
Granted: 1999-04-19
Abstract: Nucleic acid encoding pneumococcal surface protein A is disclosed both as the full sequence and as primers and probes derived therefrom, together with vectors containing the nucleic acid and methods of obtaining PspA by expression of said nucleic acid and PspA so produced.
Patent DK-0647786-T3 (DK)
Inventor: HUBL WERNER DR
IPC: F15B15/14
Filed: 1994-10-05
Granted: 1999-03-01
Abstract: A linear actuator, adapted especially for picking up and transporting workpieces, comprises a pneumatic, rodless cylinder (3) having a pair of driven elements (8, 16) mounted on opposite sides of its body. The first driven element (8) is directly connected to the piston (6) of the cylinder (3) via a sealed, longitudinal slot (5) formed in the cylinder body (1, 2) and the second driven element (16) is drivably connected to the piston (6) or first driven element (8) by a flexible drive band (24) that passes around rollers (20) mounted at opposite ends of the cylinder body (1, 2). The driven elements (8, 16) therefore move linearly in opposite directions to one other upon actuation of the rodless cylinder (3). The second driven element (16) may be fixedly secured to a stationary structure so that, upon actuation of the cylinder (3), the cylinder body (1, 2) itself and the first element (8) will simultaneously execute linear motion in the same direction whereby the first element (8), which may have a work piece gripping device mounted on it, will in effect execute double its normal stroke length. <IMAGE>
Patent DK-0652226-T3 (DK)
Inventor: SILVERBERG LEE J
IPC: C07H15/24
Filed: 1994-11-03
Granted: 2000-08-07
Abstract: Etoposide phosphate is prepared by coupling dibenzyl 4'-demethyl-4-epipodophyllotoxin-4'-phosphate with 2,3-di-O-benzyl-4,6-O-ethylene- alpha , beta -D-glucopyranose in a solvent and subsequently removing the protecting groups. The tetra-benzyl protected etoposide phosphate is recrystallized from methanol or directly crystallized from acetonitrile by adding methanol to yield substantially the pure C-1''- beta  form. The benzyl protecting groups are simultaneously removed by hydrogenation to produce etoposide phosphate in high yields. In a further embodiment, etoposide phosphate is treated with a phosphatase enzyme to yield etoposide.
Patent DK-0684769-T3 (DK)
Inventor: RECKWEG FREEK
IPC: A23D7/05
Filed: 1994-01-28
Granted: 1997-10-27
Abstract: The present invention regards a low fat spread comprising from about 30 to about 40 wt. % of a continuous fat phase and about 60 to about 70 wt. % of an aqueous phase. The fat phase further comprises a non-proteinaceous fat crystallization inhibitor in an amount of less than 0.5 wt. % and a non-proteinaceous emulsifier. The aqueous phase contains a dairy protein in an amount of less than about 0.1 wt. %.
Patent DK-0685092-T3 (DK)
Inventor: ZHENG JOE
IPC: G06K7/00
Filed: 1994-02-18
Granted: 1999-11-22
Abstract: An apparatus for illumination and imaging of a surface includes an apparatus for illuminating the surface, an apparatus for obtaining an image of the illuminated surface and providing an output signal representative of the obtained image, and an apparatus for limiting the exposure time of the image-obtaining apparatus to a selected fast exposure time less than the video frame rate of the image-obtaining apparatus. The image-obtaining apparatus may be a CCD-based camera. The CCD-based camera and the illumination apparatus may be mounted in a shroud having an opaque side wall. A first polarizing film may be provided intermediate the illumination apparatus and the surface, and a second polarizing film, having a polarization orientation orthogonal to that of the first polarizing film, may be provided intermediate the surface and the image-obtaining apparatus. Tip switches may be provided to prevent activation of the illumination apparatus and the image obtaining apparatus except when a lower edge of the shroud side wall is in contact with the surface.
Patent DK-0688060-T3 (DK)
Inventor: MARTISKAINEN MATTI
IPC: H01Q1/24
Filed: 1995-06-09
Granted: 2000-08-14
Abstract: An electrical antenna assembly includes a rod antenna (10), and a coil antenna (20) carried by one end of the rod antenna. The coil antenna has a dielectric core carried by the rod antenna and preformed with a helical recess, an electrically-conductive helical coil seated in the recess, an electrical connector connected to one end of the helical coil by a crimped solderless connection, and a dielectric sleeve enclosing the helical coil. <IMAGE>
Patent DK-0777512-T3 (DK)
Inventor: KUHN JOACHIM
IPC: A63B59/40
Filed: 1995-08-18
Granted: 1999-03-29
Abstract: Proposed is a table-tenis bat with a single-piece blade to which covering layers can be attached over the playing surface on one or both sides, the bat having a handle built round an extension of the bat blade which runs down the whole length of the handle and to which side-pieces are attached on each side. The bat has the following features: one of both of the side-pieces (2) has a recess on the side facing the blade extension, thus forming a cavity inside the handle; viewed at right angles to the handle axis, the cavities have a circular or elliptical cross section; the side-pieces (2) are joined along their whole length at their edges to the blade extension; at the end remote from the playing surface, the side-pieces (2) are open or closed off by a flexible element.
Patent DK-0781282-T3 (DK)
Inventor: NIELSEN FLEMMING ELMELUND
IPC: A61P9/00
Filed: 1995-09-12
Granted: 2000-02-28
Abstract: [1,2,4]triazolo[4,3-a]quinoxalinone compounds of general formula (I) wherein R<1> is POX'X" or alkyl substituted with COX' or POX'X", and X' and X" independently are hydroxy or alkoxy, and R<6>, R<7>, R<8> and R<9> independently are hydrogen; alkyl; halogen; NH2; NO2; CN; CF3 SO2NY'Y" or COZ' wherein Z' is NY'Y" or alkyl and Y' and Y" independently are hydrogen or alkyl; triazolyl; imidazolyl or imidazolyl substituted with phenyl or alkyl, are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters.
Patent DK-0756099-T3 (DK)
Inventor: LEPOLD HOLGER
IPC: F16D43/206
Filed: 1996-07-24
Granted: 2001-06-18
Abstract: The clutch has a first coupling element (30) which rotates on a pivot axle (20) and which has at least one first catch (42). Another coupling element (50) rotates on the pivot axle and has at least one second catch (58). An elastic energy accumulator (84) keeps the catches in a coupled position. The clutch has a holder (100) movable from an inactive to an active position after the release torque has been reached. In the active position, the holder in each rotary clutch position prevents the catches from transferring from an inactive to an active position. In the inactive position, the holder in each rotary clutch position allows the catches to transfer from an inactive to an active position.
Patent DK-0804417-T3 (DK)
Inventor: DYER ULRICH CONRAD CHIROSCIENC
IPC: C07B55/00
Filed: 1996-01-12
Granted: 2003-10-06
Abstract: An optically-enriched piperidine-2-carboxanilide compound, in which the piperidine is optionally N-alkylated, is racemised by heating the compound in an aqueous medium, provided that the medium includes an organic cosolvent if the compound is N-alkylated. This process is particularly valuable, in conjuction with a resolution process, for the manufacture of levobupivacaine.
Patent DK-0817635-T3 (DK)
Inventor: GRACHECK STEPHEN JOSEPH
IPC: A61K31/34
Filed: 1996-01-26
Granted: 2004-09-27
Abstract: Benzothiophene, benzofuran and indolethiazepinones, oxazepinones, and diazepinones are effective therapeutic agents for treating viral diseases, including those caused by herpesvirus and HIV.
Patent DK-0758989-T3 (DK)
Inventor: REYMOND PIERRE-OLIVIER
IPC: B65D41/48
Filed: 1996-03-07
Granted: 1999-11-22
Abstract: The claimed stopper (1) with a warranty strip (6) for a container such as a flask or bottle comprises a section of a cylindrical wall (2) surrounding the aperture of the container for which the stopper is intended, the wall section in question being formed on its outer face and in the vicinity of the edge as an uninterrupted circular outer beading (3). The stopper (1) comprises: a section of the cap (4) with a diameter greater than the outer diameter of the said section of the wall (2) with the outer beading (3), this section of the cap (4) being a ring-shaped part (5) and situated so as to surround the said section of the wall (2); and a warranty strip (6) arranged in the extension of the said ring-shaped part (5) and provided with a circular uninterrupted or interrupted retaining device (7), e.g. tabs. The retaining device (7) together with the outer beading (3) impedes the passage of the warranty strip (6) across said outer beading (3) in the direction of the container aperture. The proposed stopper is characterised by the fact the warranty strip (6) and retaining device (7), on the one hand, and the section of the cap (4) and ring-shaped part (5), on the other, are separate parts which are joined together so as to be detachable.
Patent DK-0839134-T3 (DK)
Inventor: ROGERS GARY A
IPC: A61P43/00
Filed: 1996-05-23
Granted: 2004-08-16
Abstract: Benzoyl piperidines and pyrrolidines and compounds of related structure are disclosed for use in enhancing synaptic responses mediated by AMPA receptors. The compounds are effective in the treatment of subjects suffering from impaired nervous or intellectual functioning due to deficiencies in the number or strength of excitatory synapses or in the number of AMPA receptors. The compounds can also be used for the treatment of non-impaired subjects for enhancing performance in sensory-motor and cognitive tasks which depend on brain networks utilizing AMPA receptors, for improving the performance of subjects with memory deficiencies, for treating depression, alcoholism and schizophrenia, and for improving memory encoding.
Patent DK-0848738-T3 (DK)
Inventor: PUZIC OLGA
IPC: E01C7/26
Filed: 1996-09-04
Granted: 2002-03-25
Abstract: The present invention provides a method of making storage-stable road paving binders by blending a minor amount of an unsaturated polymer (e.g., having at least one diene monomer) with a major amount of asphalt at an elevated temperature such that the components are sufficiently fluid to blend; treating the asphalt-polymer blend with a sulfonating agent; and stripping the treated asphalt-polymer blend at an elevated temperature with sufficient stripping gas to remove strippable sulfur moieties and to stabilize the resulting stripped, treated blend. The invention also provides asphaltic compositions made by the method. The asphaltic compositions are useful as binders in road paving applications.
Patent DK-0934402-T3 (DK)
Inventor: KATHLEEN A CLARKSON
IPC: A23K1/165
Filed: 1997-10-07
Granted: 2004-04-13
Abstract: A purified novel cellulase composition is provided which may be isolated from a fermentation culture of Trichoderma longibrachiatum and has a molecular weight of about 95-105 kD as approximated on SDS-PAGE (see FIG. 1), a pl of about 5.6-6.8 as estimated on an IEF gel and a pH optimum of about 5.0 on RBB-CMC when measured at 65 DEG  C. and pH 4 or lower at temperatures of 40 DEG  C. and 50 DEG  C.
Patent DK-0993659-T3 (DK)
Inventor: HERKEN ROLF
IPC: G06T15/80
Filed: 1998-07-02
Granted: 2006-03-27
Abstract: A computer graphics system is described in which a new type of entity, referred to as a "phenomenon," can be created, instantiated and used in rendering an image of a scene. A phenomenon is an encapsulated shader DAG comprising one or more nodes each comprising a shader, or an encapsulated set of such DAGs which are interconnected so as to cooperate, which are instantiated and attached to entities in the scene which are created during the scene definition process to define diverse types of features of a scene, including color and textural features of surfaces of objects in the scene, characteristics of volumes and geometries in the scene, features of light sources illuminating the scene, features of simulated cameras will be simulated during rendering, and numerous other features which are useful in rendering. Phenomena selected for use by an operator in connection with a scene may be predefined, or they may be constructed from base shader nodes by an operator using a phenomenon creator. The phenomenon creator ensures that phenomena are constructed so that the shaders in the DAG or cooperating DAGs can correctly cooperate during rendering of an image of the scene. Prior to being attached to a scene, a phenomenon is instantiated by providing values, or functions which are used to define the values, for each of the phenomenon's parameters, using a phenomenon editor. The phenomenon editor allows the operator to view the effects produced by various settings for the parameter values which are selected. During scene image generation, a scene image generator operates in a series of phases, including a including a preprocessing phase, a rendering phase and a post-processing phase. During a pre-processing phase, the scene image generator can perform pre-processing operations, such as shadow and photon mapping, multiple inheritance resolution, and the like. The scene image generator may perform pre-processing operations if, for example, a phenomenon attached to the scene includes a geometry shader to generate geometry defined thereby for the scene. During the rendering phase, the scene image generator renders the image. During the post-processing phase, the scene image generator may perform post-processing operations if, for example, a phenomenon attached to the scene includes a shader that defines post-processing operations.
Patent DK-1002017-T3 (DK)
Inventor: FISCHER HARTMUT RUDOLF
IPC: C08L53/00
Filed: 1998-08-07
Granted: 2003-06-10
Abstract: The invention relates to a nanocomposite material on the basis of a clay having a layered structure and a cation exchange capacity of from 30 to 250 milliequivalents per 100 gram, a polymeric matrix and a block copolymer or a graft copolymer, which block copolymer or graft copolymer comprises one or more first structural units (A), which are compatible with the clay, and one or more second structural units (B), which are compatible with the polymeric matrix.
Patent DK-1027336-T3 (DK)
Inventor: PETERS DAN
IPC: C07D417/04
Filed: 1998-10-27
Granted: 2005-01-24
Abstract: Heteroaryl diazacycloalkane derivatives (I) are new. Heteroaryl diazacycloalkane derivatives of formula (I) and their enantiomers or mixtures, isotopes and salts are new. [Image] n : 1-3 m : 0-2; R : H, alkyl, cycloalkyl, cycloalkylalkyl or aralkyl; R 1>aminophenyl; nitrophenyl; hydroxyphenyl; alkoxyphenyl; monocyclic 5-6 membered heterocyclyl (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amino, NO 2, COOR 3, CONR 2R 3, NHCO 2R 2and/or OCONR 2R 3); aryl (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amino and/or NO 2); X-alkyl-Y-alkyl (optionally alkyl substituted by alkoxy or thioalkoxy); X-(alkyl) o-aryl (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylene-dioxy, halo, CF 3, OCF 3, CN, amino and/or NO 2); X-(alkyl) o-Z (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amino and/or NO 2), monocyclic 5-6 membered heterocyclyl (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amino and/or NO 2) (sic), bicyclic heterocyclyl comprising a 5-6 membered monocyclic heterocyclyl fused to a benzene ring (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, alkoxy-alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amino, NO 2, aryl optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amine and/or NO 2) or monocyclic 5-6 membered heterocyclyl (optionally substituted by alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, cycloalkoxy, alkenoxy, alkynoxy, methylenedioxy, halo, CF 3, OCF 3, CN, amino and/or NO 2); X, Y : O, S or NH, N-alkyl or Se; o : 0 or 1 and Z : 5-6 membered monocyclic heterocyclyl. ACTIVITY : Analgesic; Neuroprotective; Nootropic; Tranquilizer; Antiinflammatory; Antiaddictive; Antismoking; Anticonvulsant; Neuroleptic; Antidepressant; Antiasthmatic; Antianginal; Antimigraine. The affinity of 1-(6-chloro-5-methoxy-3-pyridyl)-homopiperazine fumaric acid salt for nicotinic Ach receptors was investigated in a test for in vitroinhibition of 3H-cytisine binding. The compound exhibited and IC 50value of 0.0007 mu M. MECHANISM OF ACTION : Nicotinic acetyl choline receptor ligand.
Patent DK-1047669-T3 (DK)
Inventor: WAECHTLER ANDREAS
IPC: C07F9/50
Filed: 1999-01-11
Granted: 2003-03-03
Abstract: Described are bis(perfluoro-n-alkane-sulfonate) compounds, methods for preparing these compounds and use of these compounds, for example as starting materials for the synthesis of chiral and phosphine ligands for transition metal catalysts.
Patent DK-1082337-T3 (DK)
Inventor: KEPLER JOHN A
IPC: A61P15/00
Filed: 1999-05-28
Granted: 2006-12-04
Abstract: The invention is directed to a novel class of steroids which exhibit potent antiprogestational activity.